Minnesota FOIA #P009627409

Epigenetic inhibitors for the treatment of alcoholic hepatitis

This purchase order, issued on May 6, 2024, by the Twin Cities government agency, awards Mayo Clinic a contract for the supply of epigenetic inhibitors used in the treatment of alcoholic hepatitis. The total obligated and award amount is $69,321. The order specifies a single lot of the specified inhibitors. Mayo Clinic, located in Minneapolis, MN, is the awarded vendor. The procurement involves a NAICS code relevant to medical research or pharmaceuticals, though the exact code is not specified. The primary contact details for the buyer are not provided. The location of the award is Minneapolis, Minnesota, in the United States. Likely competitors for similar awards include other major medical research institutions and pharmaceutical companies.

Description

Epigenetic inhibitors for the treatment of alcoholic hepatitis